RxDoctor Payments Data

Trapper Lalli, MD

Foot and Ankle Surgery · Dallas, TXNPI 1073824496

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Linvatec Corporation at 47.8% of the total. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,223in general payments, 2019–2025

Across 171 payments — averaging $434.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$35K
  • Exactech, Inc.$12K
  • Arthrex$6K
  • Pylant Medical$4K
  • Restor3d, Inc.$4K
  • Flower Orthopedics Coporation$4K
  • plus $8K from 7 others
$17,279in research payments, 2019–2025

Across 3 payments — averaging $5759.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$15K
  • Treace Medical Concepts, Inc.$2K

What the payments were for

  • Consulting fees$32,93844%
  • Speaking & faculty fees$3,7505%
  • Grants$2,5003%
  • Travel & lodging$24,92034%
  • Food & beverage$6,0458%
  • Education$4,0715%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,223 in reported general payments places this provider in the 90th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$38,238
Medicare patients
77
Services billed
308

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium33$780
Gabapentin24$575
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$124
Tramadol Hcl27$39
Meloxicam20$24

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →